Literature DB >> 2702113

Zinc and copper balance in children on continuous ambulatory peritoneal dialysis.

T Tamura1, W H Vaughn, F B Waldo, E C Kohaut.   

Abstract

We monitored serum zinc and copper levels for 4 months in six patients treated with continuous ambulatory peritoneal dialysis (CAPD). Zinc and copper fluxes were studied during a single dialysis exchange and over a 3-day period. Routine oral trace element supplements were then discontinued for 2 months. Serum zinc levels declined but serum copper levels remained unchanged. One month after oral supplements had been restarted, serum zinc levels returned to normal and serum copper levels rose above initial values. Zinc and copper concentrations in dialysis exchange indicated that the patients absorbed zinc and lost copper in significant amounts. The patients had poor dietary intakes of both minerals. These data suggest that patients treated with CAPD benefit from oral zinc supplementation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702113     DOI: 10.1007/BF00858539

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

Review 1.  Provisional tables on the zinc content of foods.

Authors:  E W Murphy; B W Willis; B K Watt
Journal:  J Am Diet Assoc       Date:  1975-04

2.  Elevated plasma copper in chronic renal failure.

Authors:  J H Sondheimer; S K Mahajan; D L Rye; D K Abu-Hamdan; S D Migdal; A S Prasad; F D McDonald
Journal:  Am J Clin Nutr       Date:  1988-05       Impact factor: 7.045

3.  Zinc content of selected foods.

Authors:  J H Freeland; R J Cousins
Journal:  J Am Diet Assoc       Date:  1976-06

4.  Copper content of foods. Factors affecting reported values.

Authors:  J T Pennington; D H Calloway
Journal:  J Am Diet Assoc       Date:  1973-08

5.  Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients.

Authors:  K Mansouri; J A Halsted; E A Gombos
Journal:  Arch Intern Med       Date:  1970-01

6.  Zinc metabolism in renal failure.

Authors:  C J Condon; R M Freeman
Journal:  Ann Intern Med       Date:  1970-10       Impact factor: 25.391

7.  Zinc metabolism in chronic renal insufficiency with or without dialysis therapy.

Authors:  P J Aggett
Journal:  Contrib Nephrol       Date:  1984       Impact factor: 1.580

8.  Comparison of trace elements in peritoneal dialysis, hemodialysis, and uremia.

Authors:  N M Thomson; B J Stevens; T J Humphery; R C Atkins
Journal:  Kidney Int       Date:  1983-01       Impact factor: 10.612

9.  Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study.

Authors:  K B Sprenger; D Bundschu; K Lewis; B Spohn; J Schmitz; H E Franz
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

10.  A stable isotope study of copper absorption in young men: effect of phytate and alpha-cellulose.

Authors:  J R Turnlund; J C King; B Gong; W R Keyes; M C Michel
Journal:  Am J Clin Nutr       Date:  1985-07       Impact factor: 7.045

View more
  5 in total

1.  Trace element and vitamin concentrations in paediatric dialysis patients.

Authors:  Triona Joyce; Frances Court Brown; Dean Wallace; Christopher J D Reid; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2017-08-10       Impact factor: 3.714

Review 2.  Trace elements in dialysis.

Authors:  Guido Filler; Sarah Felder
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

Review 3.  Nutrition in children with CRF and on dialysis.

Authors:  Lesley Rees; Vanessa Shaw
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 4.  Optimization of Bone Health in Children before and after Renal Transplantation: Current Perspectives and Future Directions.

Authors:  Kristen Sgambat; Asha Moudgil
Journal:  Front Pediatr       Date:  2014-02-24       Impact factor: 3.418

Review 5.  Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD).

Authors:  Christina L Nelms
Journal:  Front Pediatr       Date:  2018-08-02       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.